Please login to bookmark Close
An appeals court has rejected the funder’s commission and legal fees stemming from a $64 million settlement in litigation over the failure of Banksia Securities, but granted approval to the settlement.
Generic Health wins ‘modest’ cut to Bayer’s $25M damages over Yasmin
Please login to bookmark Close
Generic Health has shaved two percent off the $25 million damages awarded pharmaceutical giant Bayer in a patent infringement case over Bayer’s blockbuster oral contraceptive, Yasmin, but the discount is a far cry from the 15 percent it sought on appeal.
Lawyers face off over competing class actions
Please login to bookmark Close
As judges grapple with fierce competition among litigation funders and law firms to lead class actions, Lawyerly asked two leading practitioners on opposing sides of the class action divide to give us their take on the issue.
Citing ‘irreparable harm’ Rush tries to keep Nationwide amendments under wraps
Please login to bookmark Close
Actor Geoffrey Rush is seeking to suppress an amended defence by Nationwide News, arguing that if they’re made public the amendments could cause him “irreparable harm”.
Judge rejects ‘problematic’ pleading in Ford class action
Please login to bookmark Close
A Federal Court judge has rejected a revised pleading in a class action against Ford over its allegedly defective PowerShift transmissions.
Seconded Ashurst lawyer was allowed at Qantas FWC hearing
Please login to bookmark Close
The presence of a seconded Ashurst lawyer at a Fair Work Commission hearing in an unfair dismissal case against Qantas did not violate an order denying the airline’s request to hire the firm to represent it in the case, the Fair Work Commission has found.
Unlockd drops competition case against Google
Please login to bookmark Close
The administrators of collapsed startup Unlockd have withdrawn the company’s case against Google alleging the search engine giant abused its dominance to keep it out of the digital ad market.
Alphapharm loses bid for docs in Sanofi injector pen patent dispute
Please login to bookmark Close
Generic drug maker Alphapharm has lost another bid for documents from Sanofi-Aventis in advance of a hearing on Sanofi’s interlocutory application seeking to block the generic drug maker from listing its injector pen on the Pharmaceutical Benefits Scheme.
Seven employee sues network for wages after exit to Ten
Please login to bookmark Close
Seven Network’s former director of program partnerships is suing the national broadcaster for putting her on unpaid maternity leave and extending her non-compete period after she resigned for rival Network Ten.
First class action to be filed over combustible cladding
Please login to bookmark Close
The first class action is expected to be filed on behalf of property owners whose buildings are covered with highly combustible polyethylene core cladding.